Great day with rich discussions. The talks all went so well together. #psychedelics #phenomenology #mentalhealth @uobphenomenal.bsky.social
Looking forward to the talks at our Psychedelics, Phenomenology, & Mental Health workshop as part of the Birmingham Network for Phenomenology & Mental Health. Sign up & schedule in the link.
And we're off to the races. Great lineup for today's @uobphenomenal.bsky.social seminar. Joined by speakers from Imperial, Exeter, Amsterdam, & Birmingham. #psychedelics #interdisciplinary #phenomenology #mentalhealth
🌿 Facing the end of life can bring immense distress. Could psychedelic therapy help ease the journey?
drugscience.org.uk/easing-end-of-life-distress-psychedelic-uk
@profjoneill.bsky.social, Laura Downey, & @profmq.bsky.social for @drugscience.bsky.social
#PalliativeCare #Psychedelics #DrugScience
đź“…Save the date! Our next Network seminar will be on "Hearing voices, suicidality, and AI-psychosis", March 20th 2026, Hybrid
This is a collaboration with @hearingvoicesmic.bsky.social and #ProjectEPIC
Find more info and registration here:
birminghamphenomenalnetwork.blogspot.com/2025/12/netw...
PSYCHLES
Pα+ Psychedelic Bulletin #207
- Lykos Rebrands to Resilient
- Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision
- AbbVie-Gilgamesh Deal Viewed as Validation
- Psilocybin Rescheduling Petition Heads to HHS
- Much, much more...
psychedelicalpha.com/news/p%ce%b1...
Facing a terminal diagnosis is one of life’s most difficult challenges. Beyond the physical burden of illness, patients often experience anxiety, depression, insomnia, and existential distress – a sen...
🍄 Our new living systematic review and meta-analysis on psilocybin for depression is out. Here's what we found and the open science infrastructure we built to support it 🧪🧵
www.medrxiv.org/content/10.1...
The Dutch Medicines Evaluation Board will host a Pipeline Meeting on 5 Nov 2025, focusing on the regulatory development of psychedelics.
Pharmaceutical companies can apply to present and discuss psychedelic development challenges with Dutch regulators.
Deadline: 29 Aug tinyurl.com/meb-pipeline...
PSYCHLES
PSYCHLES
PSYCHLES
@Drug_Science
blog on the new Compass #psilocybin for #depression study drugscience.org.uk/compass-phase3
A new excerpt from A World Appears: Minds Before Brains - by Michael Pollan - The Microdose themicrodose.substack.com/p/minds-befo...
Location In person: Assembly Room, The Exchange, 3 Centenary Square, Birmingham, B1 2DR. Online: Teams meeting. Date and time 20th March 202...
birminghamphenomenalnetwork.blogspot.com
Lykos Therapeutics Rebrands to Resilient Pharmaceuticals • Pharma Pushes Back on Norway’s Off-Label Ketamine Decision • AbbVie–Gilgamesh Deal Viewed as Validation for Short-Acting Psychedelics •
Our schedule for our next network seminar has now been finalised!
Check out our website for the full list of awesome talks:
birminghamphenomenalnetwork.blogspot.com/2025/10/netw...
P.S. there's still time to register!
Psychiatric medicine is undergoing a seismic shift as Compass pathways announce successful results from its Phase 3 trial (COMP006).
